Reproductive Genetics is the branch of science that deals with the relationship between reproduction and genotype. It involves various tests and procedures to offer needful information about the probabilities of having a child in case of any specific genetic disorder. Moreover, Reproductive Genetics further help predict & prevent genetic disorders during reproductive procedures.
The “Global Reproductive Genetics Market” is likely to grow at a CAGR of around 12% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth primarily attributes to molecular diagnostics and rising awareness regarding genetic testing & screenings. With technological advancements, genetic tests are gaining excellent popularity in reproductive procedures.
They assist in identifying the cause of infertility & carriers of inherited diseases, thereby helping in directing toward the most suitable assisted reproductive techniques. Hence, these factors are likely to fuel the Global Reproductive Genetics Market in the coming years
The research report, “Global Reproductive Genetics Market Analysis, 2021,” depicts a deep-dive market analysis of market statistics, including regional & country-wise market size, market forecast, CAGR & market share of different segments, competitive benchmarking, and key market drivers & restraints.
|Study Period||Historical Data: 2016-19|
|Base Year: 2020|
|Forecast Period: 2021-26|
|Regions Covered||North America: USA, Canada, Mexico|
|Europe: Germany, The UK, France, Spain, Italy|
|Asia-Pacific: China, India, Japan, South Korea, Australia|
|South America: Brazil, and Argentina|
|Key Companies Profiled||ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd, Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, QIAGEN NV|
|Unit Denominations||USD Million/Billion|
COVID-19 Outbreak Negatively Impacted the Global Reproductive Genetics Market
The outbreak of the COVID-19 pandemic has resulted in the governments of different nations enforcing strict movement restrictions and the shutdown of clinics. During this time, consumers shifted their preferences toward tele consulting to avoid the risk of getting infected.
Additionally, the shortage of skilled human resources, infrastructure, and logistic issues also affected the overall healthcare system. The situation worsened further due to reduced access & decline in genetic testing globally owing to the extended lockdown in all regions.
However, reproductive genetic testing companies incorporated several measures, including supply chain centralization, to recover from the losses caused by the pandemic. Hence, the market shall regain its usual pace and attain significant growth in the forecast period.
Career Screening Dominated the Global Reproductive Genetics Market with Largest Share
Based on the Procedure Type, the market bifurcates into Carrier Screening, Pre-Natal Screening, Pre-Implantation Genetic Testing, and Infertility Genetic Testing. Among these segments, Carrier Screening accounted for more than 50% of the market share in the previous few years and is likely to maintain its dominance over the forecast period.
Carrier Screening is a type of genetic test carried out on patients with a higher risk of passing on the genetic disorder to their children. The increased risk of genetic mutations and the wide-range utility of genetic testing at an early stage are the prime aspects that contributed to the adoption of Carrier Screening procedures.
Aneuploidy Captured the Significant Share of Global Reproductive Genetics Market
Based on the Application, the market divides into Aneuploidy, Structural Chromosomal Abnormality, and Single Gene Disorder. The Aneuploidy segment captured around 40% share of the Global Reproductive Genetics Market in the previous year. Most aneuploidies are considered lethal, claims experts. Additionally, their most common form is trisomy, present in 0.3% of all live births. Most cases of Aneuploidy result in miscarriage. Hence, the need for reproductive genetic consultation is significantly high in the cases of Aneuploidy, thereby propelling the overall market growth.
North America Attained the Highest Share of the Global Reproductive Genetics Market
Globally, North America acquired around 38% share of the Global Reproductive Genetics Market in the previous year. The U.S. remained the most dominating country in terms of revenue generation. Moreover, the presence of full-fledged operational units of conglomerate market players in the region is helping in the establishment of various start-up companies. Additionally, the several technological innovations of these players also propel the Global Reproductive Genetics Market.
Increasing Awareness and Acceptance for Genetic Testing and Screening
The growing literacy rate has led to a surge in the understanding levels regarding personal genomic risk, thereby impacting the public attitude and interest of the population globally. Furthermore, the rising public participation in personal genomics activities, including research and genomic services, has also fueled public awareness & understanding regarding genetics. Moreover, several educational programs run by the government and the emergence of direct-to-consumer (DTC) testing in the last few years have boosted the genomic healthcare knowledge among the population.
Stringent Regulations & Norms to Restrain the Market Growth
Various regulatory bodies worldwide restrict the use of reproductive genetics tests as the subsequent rise in uptake of Pre-Natal testing is likely to surge the incidence of abortions. Therefore, professional organizations, such as the American College of Obstetricians and Gynecologists (ACOG), International Society for Pre-Natal Diagnosis, U.S. National Society of Genetic Counselors (NSGC), and the Japan Society of Obstetrics and Gynecology, have set up a few guidelines to limit the use of non-invasive Pre-Natal testing to pregnant women at high risk of chromosomal aneuploidies, thereby likely to hinder the overall market growth.
According to MarkNtel Advisors, the leading industry players in the Global Reproductive Genetics market are ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd., Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, and QIAGEN NV.
Key Questions Answered in the Market Research Report:
Market Outlook, Segmentation, and Statistics
Frequently Asked Questions
A. The Global Reproductive Genetics Market is forecast to grow at a CAGR of 12% during 2021-26.
A. ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd., Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, and QIAGEN NV are a few of the leading players in the Global Reproductive Genetics Market.
A. The Carrier Screening segment is likely to attain the highest CAGR and maintain its significant market share during the forecast period, i.e., 2021-26.
A. North America continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global Reproductive Genetics Market.
A. The declining cost of genetic sequencing technologies, rising awareness & acceptance for genetic testing, burgeoning demand for early detection and prevention, and increasing maternal age leading to pregnancy complications are the major factors fueling the market growth.
A. The outbreak of the COVID-19 pandemic has negatively affected the Global Reproductive Genetics Market owing to the enforcement of movement restrictions, the shutdown of clinics, and logistic & infrastructure issues.